Sujal Patel is the co-founder of Nautilus Biotechnology, a company at the intersection of innovation. Nautilus is building a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Prior to Nautilus, Patel founded Isilon Systems in 2001, a storage company that built for the future of unstructured, file-based data which required a new storage paradigm. In 2006, Isilon completed one of the most successful initial public offerings of the year. From 2007 to 2010, Patel, as CEO, led Isilon during a period of profound growth, improving operating margins from -37.5% to +20%.
Isilon was acquired by EMC in December, 2010 for $2.5 Billion. Patel served as the President of EMC’s Isilon Storage Division from the acquisition until November, 2012, driving significant revenue growth, market expansion and organizational scale.
Prior to EMC and Isilon, Patel served in various engineering roles at RealNetworks, Inc., in part as chief architect behind the company’s second-generation core media delivery system.
Patel holds nineteen patents in the areas of storage, networking, and media delivery, is a well-known speaker on entrepreneurship, and has received a variety of industry awards. Currently Patel serves on the board of directors at Qumulo and Rainier Scholars.
He graduated from the University of Maryland College Park in 1996 with a degree in Computer Science.
What is Sujal M. Patel's net worth?
The estimated net worth of Sujal M. Patel is at least $26.27 million as of March 11th, 2024. Mr. Patel owns 10,064,488 shares of Nautilus Biotechnology stock worth more than $26,268,314 as of November 2nd. This net worth approximation does not reflect any other assets that Mr. Patel may own. Additionally, Mr. Patel receives an annual salary of $827,240.00 as CEO at Nautilus Biotechnology. Learn More about Sujal M. Patel's net worth.
How old is Sujal M. Patel?
What is Sujal M. Patel's salary?
How do I contact Sujal M. Patel?
Has Sujal M. Patel been buying or selling shares of Nautilus Biotechnology?
Sujal M. Patel has not been actively trading shares of Nautilus Biotechnology during the last quarter. Most recently, on Monday, March 11th, Sujal M. Patel bought 12,044 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $2.84 per share, with a total value of $34,204.96. Following the completion of the transaction, the chief executive officer now directly owns 10,064,488 shares of the company's stock, valued at $28,583,145.92. Learn More on Sujal M. Patel's trading history.
Who are Nautilus Biotechnology's active insiders?
Are insiders buying or selling shares of Nautilus Biotechnology?
In the last year, Nautilus Biotechnology insiders bought shares 3 times. They purchased a total of 38,303 shares worth more than $108,316.27. In the last year, insiders at the sold shares 2 times. They sold a total of 82,031 shares worth more than $234,728.97. The most recent insider tranaction occured on September, 23rd when VP Mary E. Godwin sold 47,031 shares worth more than $134,978.97. Insiders at Nautilus Biotechnology own 40.5% of the company.
Learn More about insider trades at Nautilus Biotechnology. Information on this page was last updated on 9/23/2024.
